Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_assertion type Assertion NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_head.
- NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_assertion description "[In contrast, p47phox, nicotinamide adenine dinucleotide phosphate oxidase 1 and nicotinamide adenine dinucleotide phosphate oxidase organizer 1 expression were more restricted to the zone of initial damage or to lesions from patients with acute or early relapsing/remitting multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_provenance.
- NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_assertion evidence source_evidence_literature NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_provenance.
- NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_assertion SIO_000772 22366799 NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_provenance.
- NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_assertion wasDerivedFrom befree-2016 NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_provenance.
- NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_assertion wasGeneratedBy ECO_0000203 NP963491.RAsw3p3L8KpVvRprB5qdHSeZC9asA6Y2RiNWPdRmOa72Q130_provenance.